We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diagnostic Technology Performs Rapid Biofluid Analysis Using Single Droplet

By LabMedica International staff writers
Posted on 04 Dec 2025

Diagnosing disease typically requires milliliters of blood drawn at clinics, depending on needles, laboratory infrastructure, and trained personnel. More...

This process is often painful, resource-intensive, and inaccessible in many regions. Existing workflows overlook the rich diagnostic information embedded in the physical changes that biofluids undergo as they dry. Now, researchers have developed an automated imaging and machine-learning system that analyzes how tiny droplets of blood and other fluids dry to distinguish normal from abnormal samples.

The automated system, developed by researchers at the University of Tokyo (Tokyo, Japan), reduces reliance on traditional phlebotomy and expensive consumables by using microscopic imaging to observe biofluid droplets drying in real time. It eliminates the need for specialized diagnostic equipment by using a simple brightfield microscope with a 4x objective lens and a digital camera.

During the drying process, droplets undergo shape changes and internal pattern evolution driven by the movement of proteins, cells, and other biomolecules. These dynamic structural changes are captured frame by frame and then interpreted by a machine-learning algorithm trained to identify disease-associated abnormalities. Because the method relies on naturally occurring drying behaviors, it can also analyze saliva and urine without additional tools.

The research team demonstrated that time-evolving droplet images provide richer diagnostic information than solely examining the final dried pattern. Their machine-learning models accurately distinguished healthy from abnormal biofluid samples across multiple conditions, including diabetes, influenza, and malaria. In validation experiments, published in Science Advances, the researchers confirmed that the real-time drying profile carries a unique signature of the fluid’s composition.

This proof-of-concept work shows how drying-based imaging can serve as a rapid, low-cost diagnostic platform suitable for global deployment, especially in low-resource settings. By relying on tiny droplets instead of venous blood draws, the method enables broader screening, improves accessibility, and reduces medical waste. The researchers envision a portable device or mobile-based workflow that could extend laboratory-grade insights to populations without access to traditional testing. Future work aims to transform the system into a practical point-of-care health-screening tool.

“Such a tool could make health monitoring faster, more affordable and more accessible, especially in communities with limited access to laboratory testing. Ultimately, our goal is to bring laboratory-level insights to the point of care, enabling early detection and preventive health care for everyone,” said Amalesh Gope, co-author of the study.

Related Link
University of Tokyo


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.